CIK 0001618835 · Non-accelerated filer<br>Smaller reporting company
Evofem Biosciences, Inc.
Sign in to watch- Ticker
- EVFM
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208527075
- Phone
- (858) 550-1900
- Business address
- 12400 HIGH BLUFF DRIVE, SUITE 600, SAN DIEGO, CA, 92130
- Former names
- Neothetics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-08-22 | Barrans Russell Chief Commercial Officer | Shares withheld for taxes | −962 | $5.13 | $5K | 216,197 |
| 2019-08-22 | Culwell Kelly Chief Medical Officer | Shares withheld for taxes | −864 | $5.13 | $4K | 54,912 |
| 2019-08-22 | Fitzpatrick Alexander A General Counsel and Secretary | Shares withheld for taxes | −1,296 | $5.13 | $7K | 97,252 |
| 2019-08-22 | File Justin J. Chief Financial Officer | Shares withheld for taxes | −1,558 | $5.13 | $8K | 217,455 |
| 2019-07-08 | Barrans Russell Chief Commercial Officer | Grant or award | +150,000 | 230,416 | ||
| 2019-07-08 | Barrans Russell Chief Commercial Officer | Shares withheld for taxes | −13,257 | $4.99 | $66K | 217,159 |
| 2019-06-30 | Lynch Thomas G Director | Option exercise | +37,500 | 212,500 | ||
| 2019-06-30 | Lynch Thomas G Director | Option exercise · Restricted Stock Units | −37,500 | 112,500 | ||
| 2019-06-10 | Barrans Russell Chief Commercial Officer | Shares withheld for taxes | −5,965 | $6.36 | $38K | 80,416 |
| 2019-06-10 | Culwell Kelly Chief Medical Officer | Shares withheld for taxes | −5,187 | $6.36 | $33K | 55,776 |
| 2019-06-10 | File Justin J. Chief Financial Officer | Shares withheld for taxes | −10,185 | $6.36 | $65K | 219,013 |
| 2019-06-10 | PELLETIER SAUNDRA L Chief Executive Officer | Shares withheld for taxes | −35,826 | $6.36 | $228K | 452,256 |
| 2019-06-10 | Fitzpatrick Alexander A General Counsel and Secretary | Shares withheld for taxes | −7,777 | $6.36 | $49K | 98,548 |
| 2019-06-10 | Invesco Ltd. 10% owner | Purchase | +2,222,222 | $4.50 | $10.0M | 11,812,910 |
| 2019-06-10 | Invesco Ltd. 10% owner | Other disposition · Warrants | −212,765 | $0.00 | $21 | 555,556 |
| 2019-06-10 | Invesco Ltd. 10% owner | Other acquisition · Right to Purchase | +555,556 | $0.00 | $56 | 555,556 |
| 2019-06-10 | PDL BIOPHARMA, INC. 10% owner | Purchase | +6,666,667 | $4.50 | $30.0M | 13,333,334 |
| 2019-06-10 | PDL BIOPHARMA, INC. 10% owner | Grant or award · Warrants (Right to Buy) | +1,666,667 | 1,666,667 | ||
| 2019-06-05 | Kamdar Kim P. Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2019-06-05 | Rutherford Colin Director | Grant or award · Stock option (right to buy) | +50,000 | 50,000 |
Page 8 of 20 · 383 trades